Nomura Micro Science (6254) Q2 2027 earnings summary

Executive summary

• H1 FY27 orders rose 227.0% YoY to ¥50,816 million, while sales fell 4.2% to ¥24,132 million and operating profit declined 61.2% to ¥1,109 million.

• Results turned to an ordinary loss of ¥164 million and net loss attributable to owners of the parent of ¥226 million, versus profits in the prior-year period.

Financial highlights

• Net sales were ¥24,132 million, down 4.2% YoY; gross profit fell to ¥4,191 million from ¥5,735 million.

• Operating profit was ¥1,109 million, down 61.2% YoY; higher project costs and SG&A weighed on profitability.

• Ordinary loss was ¥164 million versus ordinary profit of ¥2,060 million; net loss attributable to owners of the parent was ¥226 million versus profit of ¥1,413 million.

• Maintenance and consumables sales grew 26.0% YoY to ¥9,299 million, while water treatment equipment sales declined 17.2% to ¥14,406 million.

Outlook and guidance

• FY27 forecasts remain unchanged: sales ¥97,000 million (+72.5% YoY), operating profit ¥16,000 million (+140.0%), ordinary profit ¥14,000 million (+148.7%), and net profit ¥10,360 million (+171.3%).

• FY27 forecast basic EPS is ¥269.70; annual dividend forecast is ¥85 per share, with no revision to the dividend forecast.

• Newly received large-scale projects are expected to contribute to Japan sales from H2 onward.